Abstract:ObjectiveThe Consolidated Standards for Reporting of Trials (CONSORT) statement has already proved to be an efficient standard for reporting quality of randomized controlled trials (RCTs). However, most of the Chinese medical journals have not endorsed the CONSORT statement. The current situation about the reporting quality of RCTs in Chinese medical journals is still unclear. The purpose of the study was to evaluate the reporting quality of RCTs on papers published in 5 leading Chinese medical journals.MethodsWe evaluated 232 original RCT papers using a reporting quality scale based on CONSORT statement from 2001 to 2006 in 5 Chinese medical journals (Journal type 1) without adoption of CONSORT and Chinese Journal of Evidence-based Medicine (Journal type 2) which adopted CONSORT in 2004. We measured the inclusion of 26 items for the reporting quality scale and 6 core items of each RCT report, gave score to each item and calculated the total score obtained in each report and the proportion of reports including individual items. The reporting quality of RCT trials from 2001 to 2003 (pre-adoption period) was compared with that from 2004 to 2006 (post-adoption period).ResultsThe average reporting quality of RCTs was moderate (mean score, 15.18), and the mean score of the 6 core items was low (mean score, 1.09) in 5 leading journals. The difference in the total score and the score of the 6 core items between pre-adoption period (2001–2003) and post-adoption period (2004—2006) was statistically significant (P=0.003; P=0.000). Interaction between journal type and period was not significant (F=0.76; P=0.383). We concluded that the change tendency of reporting quality between Journal type 1 and 2 was not different. But as to the core items of sequence concealment and intention-to-treat analysis, the increases were greater for Journal type 2 when evaluated against Journal type 1 (P=0.038; P=0.016).ConclusionThe reporting quality of RCT trials in 5 leading Chinese medical journals is improving. However, the lack of important items in RCT trials remains a serious problem. We recommend the endorsement of the Consolidated Standards for Reporting of Trials statement in Chinese medical journals and the continuing education on evidence-based medicine in China.

Quality of Reporting in Randomized Controlled Trials of Therapeutic Cardiovascular Medical Devices.

Quality of Reporting in Surgical Randomized Clinical Trials.

Assessment of the Reporting Quality of Randomized Controlled Trials on Treatment of Coronary Heart Disease with Traditional Chinese Medicine from the Chinese Journal of Integrated Traditional and Western Medicine: A Systematic Review

Current Situation on the Reporting Quality of Randomized Controlled Trials in 5 Leading Chinese Medical Journals

The reporting standards of randomised controlled trials in leading medical journals between 2019 and 2020: a systematic review

The Quality of Reporting of Randomized Controlled Trials of Traditional Chinese Medicine: a Survey of 13 Randomly Selected Journals from Mainland China.

A Cross-sectional literature survey showed the reporting quality of multicenter randomized controlled trials should be improved

Quality reporting of randomized controlled trials on SGLT2 inhibitors for heart failure: a comprehensive assessment

Assessment Of The Reporting Quality Of Randomized Controlled Trials On The Treatment Of Diabetes Mellitus With Traditional Chinese Medicine: A Systematic Review

Assessment of the Reporting Quality of Ophthalmic Diseases Related Randomized Controlled Trials Published in SCI Journals from Mainland China

Quality Assessment of the Reporting of Randomized Controlled Trials Published in the Chinese Journal of Integrated Traditional and Western Medicine with the Revised CONSORT Statement

Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review

Quality of Reporting of Systematic Reviews and Meta-Analyses of Surgical Randomized Clinical Trials.

Impact of the Consolidated Standards of Reporting Trials (CONSORT) checklist on reporting of randomized clinical trials in traditional Chinese medicine

Assessment of the Quality of Reporting in Abstracts of Randomized Controlled Trials Published in Five Leading Chinese Medical Journals

Are Reports of Randomized Controlled Trials Improving over Time? A Systematic Review of 284 Articles Published in High-Impact General and Specialized Medical Journals

Quality of Reporting in Oncology Randomized Controlled Trials

Safety Reporting in Randomized Controlled Trial Related to Breast Cancer Published in China

Assessing the Quality of Reporting of Randomized Controlled Trials in Traditional Chinese Medicine

The reporting quality of randomized controlled trials in pharmacotherapy for pituitary adenomas

Reporting quality of heart failure randomized controlled trials 2000-2020: Temporal trends in adherence to CONSORT criteria